This year’s cohort is exceptional. It marks the first time we are including women leaders from Southern African states, thereby expanding our impact beyond East Africa. Join me in welcoming this incredible group of 30 women leaders who are committed…

At CROI 2025, Dr. Flavia Matovu Kiweewa from MU-JHU Care LTD | MU-JHU Research Collaboration presented impactful research highlighting the power of choice in HIV prevention. Her study focused on F/TAF, a daily oral Pre-Exposure Prophylaxis (PrEP) option that offers…

Dr. Kiweewa highlighted the continued importance of traditional HIV prevention methods, including the ABC approach (Abstinence, Be faithful, and Condom use), while encouraging the adoption of new scientific interventions like Lenacapavir.Details here: Read More:>>>>>

Read more>>>>>

Read more>>>>

Dr Matovu supervised the research site that discovered that the vaginal ring can work Read more>>>>>>>

Uganda is set to take significant strides in the global fight against HIV, as the Ministry of Health (MOH) sets its sights on integrating new, cutting-edge prevention methods into the country’s National HIV Combination Prevention Strategy. With the aim of…

The Uganda Ministry of Health has taken a significant step towards ending AIDS as a public health threat by 2030, embracing cutting-edge innovations in HIV prevention. Despite making progress in combating HIV, with an HIV prevalence of 5.5% among adults…

“We have seen that people can successfully pick their ARVs from these private pharmacies. So, we think it will be the same with PrEP options,” Kadama said. Read more >>>>>

Uganda is poised to adopt Lenacapavir, a groundbreaking HIV prevention method, following promising results from Gilead Sciences’ PURPOSE 1 trial. The trial, conducted in Uganda and South Africa, demonstrated 100% effectiveness in preventing HIV transmission among women and adolescent girls.…